Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer Nanotech Investing
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results Nanotech Investing
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss Nanotech Investing
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week Nanotech Investing
ARway SDK 3.1 Unveiled - Revolutionizing Large-Scale, Location-Based Augmented Reality Navigation Emerging Technology Investing
